Inari Medical Appoints Robert Warner to Board of Directors
March 01 2022 - 8:00AM
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device
company with a mission to treat and transform the lives of patients
suffering from venous and other diseases, today announced the
appointment of Mr. Robert Warner to its board of directors. Mr.
Warner will serve as a member of the Audit Committee of the board.
“We are pleased to welcome Robert as a new independent director
to our board. Mr. Warner’s decades of executive operating
experience, including internationally, will be highly valuable to
Inari as we enter the next phase of our mission to treat and
transform the lives of patients suffering from venous and other
diseases,” said Bill Hoffman, Inari’s Chief Executive Officer.
From August 2015 to February 2018, Mr. Warner served as
President and General Manager of Alcon Vision Care Franchise
(Alcon). Prior to that, Mr. Warner served as President, U.S. and
Canada, for Alcon from January 2012 to July 2015 and as President,
Canada and Latin America, for Alcon from November 2010 to January
2012. From January 2005 to October 2010, Mr. Warner served in
positions of increasing responsibility for Alcon. Mr. Warner was a
member of the Alcon Executive Leadership Team for over 10 years and
led the Alcon transition from Nestle to Novartis majority
ownership. Since August 2021, Mr. Warner has served on the board of
directors of RXSight, Inc. (NASDAQ GS: RXST), a commercial-stage
medical technology company dedicated to improving the vision of
patients following cataract surgery, where he also serves as chair
of the nominating and corporate governance committee and as a
member of the compensation committee. Mr. Warner currently serves
on the board two private medical device companies, i-Lumen
Scientific, where he is also a member of the compensation
committee, and EyeYon Medical, where he also serves as Chairman. In
addition, Mr. Warner is a board member of GRACE, the Grapevine
Relief and Community Exchange, a nonprofit relief agency that
provides vital necessities to people who are struggling with a
limited income or recent emergency. Mr. Warner holds a B.S. in
Chemistry from Pace University and an MBA from Rutgers
University.
About Inari Medical, Inc.Inari Medical, Inc. is
a medical device company with a mission to treat and transform the
lives of patients suffering from venous and other diseases. Inari
has developed two minimally-invasive, novel catheter-based
mechanical thrombectomy devices that are designed to remove large
clots from large vessels and eliminate the need for thrombolytic
drugs. The company purpose-built its products for the specific
characteristics of the venous system and the treatment of the two
distinct manifestations of venous thromboembolism, or VTE: deep
vein thrombosis and pulmonary embolism. The ClotTriever system is
510(k)-cleared by the FDA and CE Mark approved for the treatment of
deep vein thrombosis. The FlowTriever system is 510(k)-cleared by
the FDA and CE Mark approved for the treatment of pulmonary
embolism and clot in transit in the right atrium.
Investor Contact:ICR WestwickeCaroline
CornerPhone +1-415-202-5678 caroline.corner@westwicke.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2024 to Aug 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Aug 2023 to Aug 2024